Impact of fish consumption on disability progression in multiple sclerosis

被引:0
|
作者
Johansson, Eva [1 ]
Guo, Jie [2 ]
Wu, Jing [3 ]
Olsson, Tomas [1 ]
Alfredsson, Lars [3 ]
Hedstrom, Anna Karin [1 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] China Agr Univ, Dept Nutr & Hlth, Beijing, Peoples R China
[3] Karolinska Inst, Stockholm, Sweden
来源
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2025年
基金
瑞典研究理事会; 英国医学研究理事会;
关键词
MULTIPLE SCLEROSIS; Patient Outcome Assessment; EVIDENCE-BASED NEUROLOGY; SMOKING; RISK;
D O I
10.1136/jnnp-2024-335200
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Emerging evidence indicates that diet, including fish consumption, may play a role in the development and progression of multiple sclerosis (MS). We aimed to investigate the influence of fish consumption on disability progression in MS.Methods Incident cases from the population-based case-control study Epidemiological Investigation of MS (n=2719), with data on fish intake and Expanded Disability Status Scale (EDSS) outcomes, were categorised by fish consumption and followed up to 15 years post-diagnosis through the Swedish MS registry. A digital follow-up questionnaire in 2021 assessed changes in fish intake over time (n=1719). Cox regression models, adjusted for clinical and demographic variables, were used to evaluate 24-week confirmed disability worsening (CDW), and progression to EDSS 3 and EDSS 4.Results Higher total consumption of lean and oily fish at diagnosis was associated with a reduced risk of CDW (HR 0.66, 95% CI 0.51 to 0.86), EDSS 3 (HR 0.55, 95% CI 0.39 to 0.79) and EDSS 4 (HR 0.57, 95% CI 0.33 to 0.96) compared with low consumption. These associations showed significant trends and remained consistent after further adjustment for various lifestyle factors. The protective effects were more pronounced among patients who maintained consistent fish consumption during the follow-up period.Conclusions Our findings suggest that higher fish consumption is associated with more favourable MS disability progression, supporting diet as a potentially modifiable factor. Replication and validation are needed before transfer to practice.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Drug Slows Disability Progression in Multiple Sclerosis
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (20): : 2069 - 2069
  • [22] Dairy consumption is not associated with disability progression in an Australian longitudinal cohort study of people with multiple sclerosis
    Papendorf, H.
    Daly, A.
    Black, L.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2023, 82 (OCE2)
  • [23] Pre- and post-progression relapses impact disability in progressive multiple sclerosis
    Soldan, M. M. Paz
    Novotna, M.
    Crusan, D. J.
    Atkinson, E. J.
    Kantarci, O. H.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 65 - 65
  • [24] The impact of HLA-DRB1 on disability progression in a Spanish multiple sclerosis population
    Romero-Pinel, L.
    Pujal, J. M.
    Gubieras, L.
    Matas, E.
    Bau, L.
    Martinez-Yelamos, S.
    Arbizu, T.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S65 - S66
  • [25] Impact of ocrelizumab on reducing more severe disability progression in primary progressive multiple sclerosis
    Kappos, L.
    Giovannoni, G.
    de Seze, J.
    Montalban, X.
    Wolinsky, J.
    Belachew, S.
    Deol-Bhullar, G.
    Han, J.
    Julian, L.
    Hauser, S. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 44 - 44
  • [26] Long-term impact of spinal cord reserve on disability progression in multiple sclerosis
    Ajdinaj, Paola
    Pareto, Deborah
    Alberich, Manel
    Tintore, Mar
    Montalban, Xavier
    Rovira Canellas, Alex
    Sastre-Garriga, Jaume
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 540 - 541
  • [27] Impact of insulin resistance and metabolic syndrome on disability and disease progression in patients with multiple sclerosis
    Soliman, R. H.
    Hassan, A.
    Farhan, H. M.
    Hegazy, M.
    Oraby, M. I.
    Kamel, S. H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 487 - 487
  • [28] Disability progression in multiple sclerosis is faster than observed
    Brown, M. G.
    Kirby, S.
    Asbridge, M.
    McKelvey, R.
    Murray, T. J.
    Lethbridge, L.
    Andreou, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 304 - 304
  • [29] The grey matter basis of disability progression in multiple sclerosis
    Calabrese, M.
    Poretto, V.
    Favaretto, A.
    Seppi, D.
    Alessio, S.
    Rinaldi, F.
    Perini, P.
    Gallo, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 121 - 122
  • [30] CSF oligoclonal bands and progression of disability in multiple sclerosis
    Koch, M.
    Heersema, D.
    Mostert, J.
    Teelken, A.
    De Keyser, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (04) : E24 - E24